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Abstract 
 
Background 
Surgical site infection has been estimated to occur in about 15% of clean surgery and 30% of contaminated 
surgery. Using plastic adhesive drapes to protect the wound from organisms that may be present on the 
surrounding skin during surgery is one strategy used to prevent surgical site infection. Results from non-
randomised studies have produced conflicting results about the efficacy of this approach but no systematic 
review has been conducted to date to guide clinical practice. 
 
Objectives 
To assess the effect of adhesive drapes used during surgery on surgical site infection, cost, mortality and 
morbidity. 
 
Search strategy 
We searched the Cochrane Wounds Group Specialised Register (last searched 24/4/07), the Cochrane 
Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2,2007), Ovid MEDLINE 
(1950 to April Week 2, 2007), Ovid EMBASE (1980 to 2007 Week 16), and Ovid CINAHL (1982 to 1980 to 
April Week 2 2007). 
 
Selection criteria 
Randomised controlled trials comparing any plastic adhesive drape with no adhesive drape, used alone or in 
combination with woven (material) drapes or disposable (paper) drapes in patients undergoing any type of 
surgery. 
 
Data collection & analysis 
Two authors independently selected and assessed studies for trial quality and both independently extracted 
data. Study authors were contacted for additional information. 
 
Main results 
This review includes five studies involving 3,082 participants comparing adhesive drapes with no drape and 
two studies involving 1,113 participants comparing iodine-impregnated adhesive drapes with no drape. A 
significantly higher proportion of patients in the adhesive drape group developed a surgical site infection 
when compared with no drape. (Relative Risk (RR) 1.23, 95% Confidence Intervals (CI) 1.02 to 1.48, 
p=0.03). Iodine-impregnated adhesive drapes had no effect on the surgical site infection rate (RR 1.03, 95% 
CI 0.064 to 1.66, p=0.89). Length of hospital stay was similar in adhesive drape and non-adhesive drape 
groups. 
 
Reviewers' conclusions 
There was no evidence from the seven trials that plastic adhesive drapes reduces surgical site infection rate 
and some evidence that they increase infection rates.  
 
Further trials may be justified using blinded outcome assessment to examine the effect of adhesive drapes 
on surgical site infection based on different wound classifications.  
 
Background 
Description of the condition. 
Surgical site infection (SSI) is one of the most common postoperative complications and has been estimated 
to occur in about 15% of cases of clean surgery and 30% of contaminated surgery cases (Bruce 2001). SSI 
is associated with longer recovery and further risks of additional complications, therefore increasing the risk 
of morbidity and mortality (Mangram 1999). However the incidence rate depends on a number of factors 
including the definition of infection used, the intensity of surveillance, whether patients are followed-up after 
discharge and the prevalence of risk factors in the population studied (Smyth 2000). Risk factors associated 
with SSI have been grouped into two main categories: patient or host-related and operation or procedure-
related (Mangram 1999; Smyth 2000). Patient characteristics include age, obesity, co-morbidities such as 
diabetes, remote infection, American Society of Anestheologists score (ASA) status, immunosuppressive 
therapy and length of pre-operative hospital stay. Operative risk factors include length of surgery, skin 
preparation (including shaving and antiseptic skin preparation), type of procedure, antimicrobial prophylaxis 
and surgical technique (Mangram 1999; Smyth 2000). Surgical wounds are frequently classified as either 
'clean', 'clean contaminated', 'contaminated' or 'dirty-infected' with the later categories associated with a 
higher infection rate (Lilani 2005). Many countries now benchmark their SSI rate using the National 
Nosocomial Infections Surveillance (NNIS) system risk index, in which wound classification is combined with 
the ASA status, length of surgery and whether surgery was undertaken laparoscopically to assess risk of 
SSI (Gaynes 2001). The additional per patient cost of surgical site infection has been estimated to be 
between £959 for abdominal hysterectomy to £6103 for limb amputation (Coello 2005).  
 
Description of the intervention.  
The high additional costs associated with SSI have led to the adoption of strategies that could reduce the 
incidence of SSI. These strategies include administration of prophylactic antibiotics, use of antiseptic 
solutions for skin preparation, and the use of sterile disposable materials. One of the commonly used 
operative strategies to reduce SSI is the plastic adhesive drape (referred to hereafter as adhesive drape). 
This was first tested 50 years ago on a cohort of patients undergoing a range of abdominal surgeries (Payne 
1956). The study had three main aims; 1) to test adherence of a polyvinyl drape to the skin; 2) to assess the 
level of wound contamination; and 3) to assess skin and wound reaction to the drape. Problems were found 
with adherence of the drape to the skin, despite trialing a number of skin preparation solutions. Positive 
cultures were recovered from two of the 51 wounds but no skin or wound reactions to the polyvinyl sheet 
were recorded. Since that time, use of adhesive drapes has become widespread and the product has 
undergone modifications to improve effectiveness (Ritter 1988; Yoshimura 2003). This review will focus on 
plastic (defined as polyethylene or polyurethane or polyvinyl) adhesive drapes through which an incision is 
made; for example OpSite (Smith and Nephew); Ioban (3M Company, USA), Steridrape (3M United 
Kingdom). Drapes may be either plain or impregnated with an antibacterial agent such iodine.  
 
How the intervention might work. 
For most SSIs, the source of the invading pathogen is the patient's skin (Nichols 1996). Consequently, pre-
operative skin preparation is intended to render the skin as free as possible from endogenous bacteria that 
may enter the surgical wound. Although skin disinfection prior to surgery drastically reduces the number of 
bacteria on the skin's surface, re-colonisation with bacteria from deeper skin layers and hair follicles may 
occur during the operation (Fleischmann 1996). Sterile surgical drapes, made of either linen or impervious 
paper, are used to prevent any contact with unprepared surfaces. Adhesive drapes are also used for this 
purpose and, generally used in combination with other draping techniques but have an additional function. 
Theoretically, they act as a microbial barrier, to prevent migration of contaminating bacteria from the skin to 
the operative site, for which there is some evidence (French 1976; Ha'eri 1983).  
 
Why it is important to do this review. 
Although there is theoretical plausibility for the use of adhesive drapes, conflicting reports have been 
published regarding their usefulness in limiting bacteria around the surgical site (Lilly 1970; Katthagen 1992) 
and for preventing SSI (Ritter 1988). In a related systematic review, Edwards et al, found no benefit in using 
iodophor impregnated adhesive drapes to prevent post operative surgical wound infection, when they were 
used as part of preoperative skin antisepsis (Edwards 2004). As there has been no systematic review of the 
possible benefits and harms of adhesive drapes and because their use is widespread, this review is justified 
to guide practice. 
 
Objectives 
The primary objective of this systematic review is to assess the effect of adhesive drapes used during 
surgery on SSI rates. 
 
The secondary objectives are: 
(a) to determine the cost effectiveness of using adhesive drapes; 
(b) to assess if there are any adverse effects associated with the use of adhesive drapes; 
(c) to determine whether different types of adhesive drapes (polyethylene/polyurethane/polyvinyl) have 
differential effects on SSI. 
 
Criteria for considering studies for this review 
 
Types of studies 
Randomised controlled trials (RCTs) were included if they evaluated the effectiveness of adhesive drapes 
(used alone or in combination with other drapes), in preventing surgical site infection.  
 
Types of participants 
Trials recruiting people of any age or gender, undergoing any type of inpatient or outpatient surgery, were 
considered for inclusion.  
 
Types of interventions 
The primary intervention was adhesive drapes (polyethylene, polyurethane or polyvinyl), through which an 
incision is made. Adhesive drapes may have been used alone or in combination with other drapes: woven 
(material) drapes or disposable (paper) drapes and with any antiseptic skin preparation. The comparison 
intervention was no adhesive drape; other drapes such as woven (material) drapes or disposable (paper) 
drapes may have been used. Trials evaluating plastic 'ring drapes' or 'V' drapes were excluded as the 
incision is not made through the drape. 
 
Comparisons included:  
 
• Adhesive drape (without added antimicrobial properties) compared with no adhesive drape; 
• Adhesive drape (with added antimicrobial properties) compared with no adhesive drape; 
 
 
Types of outcome measures 
Primary outcome 
Trials reporting the following primary outcome were included:  
• Rates of surgical site infection.  
For the purposes of this review we accepted the definition of surgical site infection used in the trial. 
 
Secondary outcomes  
Studies reporting secondary outcomes were only included if the primary outcome was also included and 
were:  
• Mortality (any cause); 
• Length of hospital stay; 
• Costs; 
• Hospital re-admissions; 
• Adverse reactions (e.g. contact dermatitis, anaphylaxis); 
• Other serious infection or infectious complication such as septicaemia or septic shock. 
 
 
Search strategy for identification of studies 
We performed an initial search using the Cochrane Wounds Group Specialised Register (last searched 
Searched 24/4/07). Trials on the register are identified by hand searching of relevant journals, conference 
proceedings, and searching electronic databases. We also carried out searches of electronic databases 
including the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 
2,2007), Ovid MEDLINE (1950 to April Week 2 2007), Ovid EMBASE (1980 to 2007 Week 16), and Ovid 
CINAHL (1982 to April Week 2 2007). The MEDLINE search was combined with the Cochrane highly 
sensitive search strategy for identifying reports of randomised controlled trials (Higgins 2005). EMBASE and 
CINAHL searches were combined with the trial filters developed by the Scottish Intercollegiate Guidelines 
Network (SIGN). We contacted researchers and manufactures in order to obtain any unpublished data. 
Reference lists of potentially useful articles were also searched. There were no restrictions by language, 
date or publication status. 
 
We searched The Cochrane Central Register of Controlled Trials (CENTRAL), (The Cochrane Library, latest 
issue) using the following strategy: 
 
#1 MeSH descriptor Surgical Wound Infection explode all trees 
#2 MeSH descriptor Surgical Wound Dehiscence explode all trees 
#3 MeSH descriptor Infection Control explode all trees 
#4 surg* NEAR/5 infection* 
#5 surg* NEAR/5 wound* 
#6 wound* NEAR/5 infection* 
#7 (postoperative or post-operative) NEAR/5 infection* 
#8 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7) 
#9 plastic NEAR/3 drape*:ti,ab,kw 
#10 adhes* NEAR/3 drape*:ti,ab,kw 
#11 skin NEAR/3 drape*:ti,ab,kw 
#12 incis* NEAR/3 drape*:ti,ab,kw 
#13 iodophor NEAR/3 drape*:ti,ab,kw 
#14 iodine NEAR/3 drape*:ti,ab,kw 
#15 (#9 OR #10 OR #11 OR #12 OR #13 OR #14) 
#16 (#8 AND #15) 
 
Methods of the review 
Study selection 
Two authors independently assessed the title and abstracts of references identified by the search strategy. 
We then retrieved full reports of all potentially relevant trials for further assessment of eligibility based on the 
inclusion criteria. We settled differences of opinion by consensus or referral to the editorial base of the 
Wounds Group. There was no blinding of authorship. 
 
Methodological quality assessment 
Two authors independently assessed the quality of eligible trials, using a pre-defined quality assessment 
form, based on the assessment criteria outlined below. Disagreements between authors were again 
resolved by consensus or referral to the editorial base of the Wounds Group. We contacted investigators of 
included trials to resolve any ambiguities.  
 
Trials that met eligibility criteria were assessed in the following way: 
 
For generation of random allocation sequence  
A Adequate (if the method used is described and the resulting sequences are unpredictable); 
B Unclear ( if the method was not described); 
C Inadequate (for sequences such as alternative allocation). 
 
For allocation concealment 
A Adequate (if participants and the investigators enrolling participants could not foresee assignment); 
B Unclear (method not described); 
C Inadequate (if investigators enrolling participants could foresee next assignment). 
 
For blinding of outcome assessment  
A Adequate (if the outcome was assessed by someone who is unaware of group assignment); 
B Unclear (if the method of assessment was not described); 
C Inadequate (if the outcome was assessed by someone who is aware of group assignment).  
 
For intention to treat analysis (analysed according to allocated treatment group, irrespective of adherence to 
treatment)  
A Yes; 
B Cannot tell;  
C No.  
 
For completeness of primary outcome reporting  
A Adequate (more than 90% of all participants randomised were included in the analysis); 
B Unclear (not clear how many participants were originally randomised); 
C Inadequate (less than 90% of those randomised were included in the analysis).  
 
We defined high quality trials as those receiving an A rating for the criterion of allocation concealment 
(central computerised randomisation service or sealed opaque envelopes) and for blinding of outcome 
assessment.  
 
Data extraction 
Two authors independently extracted the following data, using a piloted data extraction sheet: type of study, 
country, study setting, number of participants, sex, mean age, type of surgery, pre-operative wound 
classification, predisposing risk factors by treatment groups, type of drape, draping procedure, type of pre-
operative skin preparation, prophylactic or therapeutic antibiotic use, all primary and secondary outcome 
measures reported and authors' conclusions. Clarification about aspects of the trial were required from all of 
the authors; five were untraceable (Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 1977; Ward 2001). 
Additional trial details were received from Dewan 1987 and from the second author of the Segal 2002 trial. 
We also contacted manufacturers of plastic adhesive drapes (Johnson & Johnson, 3M Company and Smith 
& Nephew) to request details of any unpublished trials. A representative of each of these manufacturers 
responded; no current trials are underway and they were unaware of any unpublished trials. 
 
Data synthesis 
We analysed data using the RevMan 4.2.7 software. One author entered the data and the other author cross 
checked the printout against their own data extraction forms. Relative risks (RR) and 95% confidence 
intervals (CI) were calculated for dichotomous outcomes (relative risk is the risk of infection in the 
intervention group divided by the risk of infection in the control group; a relative risk of less than one 
indicates fewer infections in the intervention or adhesive drape group). Mean differences and 95% CI were 
calculated for continuous outcomes. Where appropriate, results of comparable trials were pooled using a 
fixed-effect model and the pooled estimate together with its 95% CI are reported. Heterogeneity was tested 
for using the chi-squared statistic with significance being set at p < 0.10. In addition, the degree of 
heterogeneity was investigated by calculating the I2 statistic (Higgins 2002). If evidence of significant 
heterogeneity was identified (>50%), we explored potential sources of heterogeneity and a random-effects 
approach to the analysis was undertaken. We conducted a narrative review of eligible studies where 
statistical synthesis of data from more than one study was not possible or considered not appropriate.  
 
We included all eligible trials in the initial analysis and carried out pre-planned sensitivity analyses to 
evaluate the effect of trial quality. This was done by excluding trials most susceptible to bias based on the 
quality assessment: those with inadequate allocation concealment and uncertain or unblinded outcome 
assessment.  
We had planned four sub-group analyses: 
 
(1) Clean surgery compared with contaminated surgery 
(2) Individual compared with cluster allocation 
(3) Prophylactic antibiotic compared with no prophylaxis 
(4) Hair clipping compared with shaving 
 
The only sub-group analysis that was possible based on available data was of clean compared with 
contaminated surgery.  
Nor was it possible to undertake a planned sensitivity analysis based on the type of material the drape was 
made from due to insufficient detail about the products. 
 
Description of studies 
The search identified 84 possibly relevant titles, of these 19 were still considered potentially useful after the 
titles were screened. Abstracts or full-texts were retrieved and reviewed against the inclusion criteria, 
independently, by the two authors. The Table: Characteristics of excluded studies contains reasons for 
excluding 11 of these studies. In summary, four were not RCTs (Duvvi 2005; Fairclough 1986; Maxwell 
1969; Yoshimura 2003), three did not report SSI rates (French 1976; Ha'eri 1983; Manncke 1984), one did 
not report the number of participants in each group (Lewis 1984) and an adhesive drape was not used in the 
remaining three trials (Nystrom 1980; Nystrom 1984; Williams 1972). One further trial, in German, is 
awaiting assessment (Breitner 1986).  
 
Seven RCTs (Chiu 1993; Cordtz 1989 Dewan 1987; Jackson 1971; Psaila 1977; Segal 2002; Ward 2001) 
met the inclusion criteria (Table: Characteristics of included studies). These seven trials of 4,195 participants 
were included in the review with individual trial sizes ranging between 141 to 1,340 participants. Five of the 
trials compared an adhesive drape with no adhesive drape (Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 
1977; Ward 2001) and two compared an iodine-impregnated adhesive drape with no adhesive drape 
(Dewan 1987; Segal 2002). One study was a multi-centre trial (Cordtz 1989); the remaining trials were 
single centre. An a priori sample size calculation, based on a 50% reduction on the infection rate, was 
reported in one study (Ward 2001). Segal 2002 reported a sample size calculation based on an analysis of 
results of a pilot study of 120 patients, the trial was then continued, recruiting a further 64 patients.  
 
Surgical procedures included caesarean section (Cordtz 1989; Ward 2001), general or abdominal surgery 
(Dewan 1987; Jackson 1971; Psaila 1977), hip surgery (Chiu 1993) and cardiac surgery (Segal 2002). 
Surgical site infection was not defined in one study (Chiu 1993); the Table: Characteristics of included 
studies contains details of other definitions used. 
 
Four trials used iodine and alcohol to prepare the operative site (Chiu 1993; Cordtz 1989; Dewan 1987; 
Jackson 1971); one used Savlon and alcoholic chlorhexidine (Psaila 1977); an iodophor/alcohol water 
insoluble film was used in the Segal 2002 trial; and in the Ward 2001 trial, skin was swabbed with alcoholic 
chlorhexidine. In the Cordtz 1989 trial, participants were also randomised to have their wound re-disinfected 
prior to wound closure. Jackson 1971 ran a concurrent test of antibiotic spray in random cases. 
 
Prophylactic cephalosporin was given to each patient at anaesthetic induction in the Chiu 1993 trial and all 
patients in the Ward 2001 trial received 1G of cephazolin when the baby's cord was clamped, unless 
antibiotics were already being administered for therapy or prophylaxis. Antibiotic use was recorded by 
Cordtz 1989 and Segal 2002 but not reported by group. No information about antibiotic use was provided by 
other authors (Dewan 1987; Jackson 1971; Psaila 1977). 
 
Methodological quality of included studies 
Generation of random allocation sequence 
In all trials, authors stated that participants were randomly allocated to the intervention. It was unclear how 
the allocation sequence was generated in three trials (Chiu 1993; Psaila 1977; Segal 2002). In the Cordtz 
1989 trial, the National Centre for Hospital Hygiene was responsible for the randomisation process; Dewan 
1987 and Ward 2001 used a random number table and in the Jackson 1971 trial, a 'spin of the coin' was 
used.  
 
Allocation concealment 
Allocation concealment was adequate (rated A) in three studies. Segal 2002 asked surgeons participating in 
the trial to draw the treatment allocation from a 'closed sack' at the beginning of surgery and Ward 2001 and 
Dewan 1987 used sealed envelopes for group allocation. In other studies the information was not available 
to judge (rated B), although authors were contacted where possible (Chiu 1993; Cordtz 1989; Jackson 
1971;Psaila 1977).  
 
Blinding of outcome assessment  
In the Ward 2001 and Dewan 1987 trials, outcomes were assessed by staff who were unaware of group 
assignment. The study investigators inspected wounds for signs of infection in the Jackson 1971 and Segal 
2002 trials. In all other trials it was unclear who was responsible for assessing outcomes, and whether those 
who did inspect wounds for signs of infection were aware of group assignment (Chiu 1993; Cordtz 1989; 
Psaila 1977).  
 
Intention to treat analysis  
None of the trials reported group assignment violations, so it is difficult to assess whether patient outcomes 
were analysed in the group to which they were assigned. None of the trials specifically reported that they 
used an intention to treat analysis. 
 
Baseline comparability 
No information was available about baseline comparability for five trials (Chiu 1993; Cordtz 1989; Jackson 
1971; Psaila 1977; Segal 2002). In the Dewan 1987 trial, the author stated that groups were similar for all 
risk factors but no data was presented. Ward 2001 stated that, apart from age and parity, groups were 
comparable at baseline but again, no data were available for comparison. 
 
For completeness of primary outcome reporting  
One trial did not indicate the period of follow-up (Psaila 1977). In the remaining trials, follow-up ranged 
between 5 days and 6 months (Table: Characteristics of included studies). In the Dewan 1987 trial, 46 
patients (4.2%) were unable to be tracked and were excluded from the analysis. Based on reported data, 
follow-up appeared to be complete in all of the other included trials. However, the absence of detailed 
participant flow charts, or any reference to the number who started the trial and were unable to be followed-
up, makes assessment of rates difficult, particularly as the follow-up periods were lengthy in some studies, 
increasing the likelihood of incomplete follow-up.  
 Results 
This review includes seven studies involving 4,195 participants of whom 2,133 were in the treatment group 
and 2,062 formed the control group. All seven trials recorded incidence of surgical site infection as an 
outcome. Surgical procedures included general or abdominal surgery (Dewan 1987; Jackson 1971; Psaila 
1977), Caesarean section (Cordtz 1989; Ward 2001), cardiac surgery (Segal 2002) and hip surgery (Chiu 
1993). Based on our quality criteria, the trials of Dewan 1987 and Ward 2001 were considered to have a low 
risk of bias. The remaining five trials Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 1977; Segal 2002 
contained a moderate risk of bias ( Higgins 2002, section 6.7.1). However, as results from all trials were not 
dissimilar, all of the eligible trials were combined in the meta-analyses. 
 
Two comparisons were undertaken: adhesive drapes compared with no adhesive drapes (Analysis 01) (Chiu 
1993; Cordtz 1989; Jackson 1971; Psaila 1977; Ward 2001) and iodine-impregnated adhesive drapes 
compared with no adhesive drapes (Analysis 02) (Dewan 1987; Segal 2002).  
 
Adhesive drape compared with no adhesive drape (Analysis: 01) 
 
PRIMARY OUTCOMES 
 
Surgical site infection (SSI) (Analysis 01:01) 
Five studies were included in this comparison (Jackson 1971; Psaila 1977; Cordtz 1989; Chiu 1993; Ward 
2001). These studies included 3,082 participants, of whom 1,556 were in the adhesive drape group and 
1,526 were in the no adhesive drape group. Although the studies covered a 30 year time span and included 
a range of different types of surgery, no heterogeneity was detected (I2 = 0%). Pooling these studies (fixed 
effect model) indicated significantly more SSIs in the no adhesive drape group, (RR 1.23, 95% CI 1.02 to 
1.48, p=0.03). The overall event rate was 13.7% and 11.2% in the adhesive drape group and no drape 
group respectively.  
 
Surgical site infection - by preoperative wound classification (Analysis 01:02) 
A single trial of 921 participants analysed infection rates based on pre-operative infection risk classifications 
(Jackson 1971). In this trial there was no significant effect of using an adhesive drape overall, although 
infection rates were lower for the no adhesive drape group. Results did not vary depending on baseline risk 
of infection. Overall RR = 1.20 (95% CI 0.86 to 1.66). RR for clean wounds = 1.37 (95% CI 0.53 to 3.53); RR 
for potentially infected wounds = 1.24 (95% CI 0.80 to 1.92); RR for infected wounds = 1.03 (95% CI 0.60 to 
1.75). We have reported results from this trial as they were presented in the published paper, even though 
there was a minor discrepancy between results in the text and those in the tables. For example, in the text, 
52 of the 448 cases in the in the no adhesive drape group became infected. In the table, when cases were 
classified as clean, potentially infected and infected, totals were 51 infections among 445 cases. Similarly in 
the adhesive drape group, 67 infections were reported in 473 patients in the text and 67 of 476 in the tables. 
Attempts to contact investigators were unsuccessful however, using either set of results did not affect the 
overall level of significance for this outcome.  
 
SECONDARY OUTCOMES 
 
Length of stay (Analysis 01:03) 
Ward 2001 was the only trial to report length of stay. The analysis was divided into two sub-groups: length of 
stay for those with a SSI (n = 64) and those without a SSI (n = 539). In the infected sub-group, the mean 
length of stay in the adhesive drape group was 10.4 days (SD 3.9 days), this was not statistically different 
from the mean length of stay in the no adhesive drape group (10.2 days, SD 3.9 days). Length of stay was 
much shorter among those without a SSI. In the adhesive drape group it was 5.2 days (SD 1.3 days) and 
also 5.2 days (SD 1.3 days) in the no adhesive drape group. No statistical difference in length of stay was 
found between the adhesive drape and no adhesive drape groups in either of these sub-groups.  
 
None of the trials provided information about any of the other pre-defined secondary outcomes (mortality, 
cost, hospital re-admissions, adverse reactions e.g. contact dermatitis, anaphylaxis) or other serious 
infection or infectious complication such as septicaemia or septic shock. 
 
Iodine-impregnated adhesive drapes compared with no adhesive drape (Analysis:02) 
 
PRIMARY OUTCOME 
 
Surgical site infection (Analysis 02:01) 
Two studies compared iodine-impregnated adhesive drapes with no adhesive drapes (Dewan 1987; Segal 
2002). These studies included 1,113 participants, of whom 577 were in the iodine-impregnated adhesive 
drape group and 536 were in the no adhesive drape group. In the absence of heterogeneity (I²=0%) the 
studies were pooled. There was no significant difference in SSI rates between the two groups; RR 1.03 
(95% CI 0.66 to 1.60, p=0.89).  
 
Discussion 
Although adhesive drapes are widely used in surgery to prevent SSIs, an evidence based guideline for their 
use is unavailable (Mangram 1999). Consequently, the primary focus of this review was to address the 
effectiveness of adhesive drapes in preventing surgical site infection. Seven studies encompassing more 
than 4,000 patients were identified. The main finding of this review is that adhesive drapes are not 
associated with a reduced infection rate compared with no adhesive drapes and appear to be associated 
with an increased risk of infection. The most obvious explanation for the result is that, if adequately 
disinfected prior to surgery, the patient's skin is unlikely to be a primary cause of SSI; so attempts to isolate 
the skin from the wound, using an adhesive drape, may be pointless and potentially harmful as excessive 
moisture under plastic drapes may encourage bacteria residing in hair follicles to migrate to the surface and 
multiply (Chiu 1993).  
 
In the only trial to report on length of stay, the use adhesive drapes did not appear to be affect the duration 
of hospitalisation. There was no available evidence for our other pre-planned outcomes of interest; mortality, 
cost, hospital re-admissions or adverse reactions. 
 
Three of the trials included in the review had concurrent interventions. Segal 2002 had four arms to the 
study, two of which did not involve a comparison between draping methods. In the analysis, we included the 
two arms of the study that included a draping comparison only. We believe it is unlikely that this design 
would have had an impact on the outcome as patients were mutually exclusive. Similarly, in the Psaila 1977 
trial, ring drapes were used in a third group. Cordtz 1989 allocated patients to four groups, adhesive drape 
or no drape adhesive drape combined with re disinfection or no re-disinfection. Although there was a lower 
rate of SSI in the re-disinfection group, the reduction was similar irrespective of the type of drape used.  
 
Studies were of variable quality with only two trials (Ward 2001; Dewan 1987) meeting our criteria for high 
quality (receiving an A rating for the criterion of allocation concealment and for blinding of outcome 
assessment). Reporting aspects of other trials were poor, making it difficult to assess study quality. 
However, results of all but one of the trials were in a similar direction, favouring no adhesive drapes, 
providing some confidence in results. Verification remains a problem with many older studies, where contact 
with authors is impossible. Only the Psaila 1977 trial had a non-significant trend favouring adhesive drapes. 
This was a small study of 116 participants, the authors randomly allocated patients to two groups (adhesive 
drape and ring drape) and then stated, "in a control group linen towels alone were used". We included 
outcomes from the control group in this study as the 'no adhesive drape' group in our analysis, but it was 
unclear how this group was selected. We are uncertain if any publication bias affected results, no 
unpublished studies were found. 
 
Finally, it is unclear if all of the products used in the trials were similar. Trade names of adhesive drapes 
have changed over the 30 year time span this review covers. Whether this has led to a qualitative 
improvement in the product is unclear. No specific details were provided about, for example, the density of 
the material or its adherability. Irrespective of this, results have remained consistent over time suggesting 
that any improvements or changes to the product have not affected SSI rates.  
 
Reviewers' conclusions 
 
Implications for practice 
Evidence from this review suggests that use of intraoperative, incisional adhesive drapes is unlikely to 
reduce SSI rates and may increase them. 
 
Implications for research 
A large, high quality definite RCT may be warranted to determine whether modern adhesive drapes do 
prevent or reduce SSI.  
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